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Summary
Treatment of porcine kidney (PK-15) cells with
either interferon-gamma (IFN-g) or endosomal-
lysosomal system acidification inhibitors increases
replication of porcine circovirus type 2 (PCV2). In
the present study, the effect of a combination of
these treatments on the number of infected cells
and virus yield was tested. The number of PCV2
(Stoon-1010)-infected PK-15 cells increased in
cells treated with ammonium chloride (445 39%
increase), IFN-g (446 8%), ammonium chlorideþ
IFN-g (1721 283%), chloroquine diphosphate
(1037 121%), chloroquine diphosphateþ IFN-g
(2199 255%), monensin (950 178%) and
monensinþ IFN-g (1948 60%). Combined IFN-
g and endosomal-lysosomal system acidification
inhibitors increased PCV2 yield by up to 50 times
compared to untreated PK-15. This augmented vi-
rus replication in PK-15 cells may be helpful in the
production of PCV2 vaccines.

Porcine circovirus type 2 (PCV2) is a member
of the genus Circovirus, family Circoviridae [30].
PCV2 infections are mainly associated with a mul-
tifactorial disease in pigs, postweaning multisyste-
mic wasting syndrome (PMWS) [1, 7, 9, 12, 17,
27]. Apart from PMWS, PCV2 has also been as-
sociated with various disease syndromes in pigs
including porcine dermatitis and nephropathy syn-
drome [3, 5, 19, 21, 31, 35, 37], congenital tremors
[6, 14], reproductive failure [16, 18, 21, 28, 29,
33], exudative epidermitis [38], porcine respiratory
disease complex [13], proliferative and necrotizing
pneumonia [11] and enteritis [4, 15]. In vitro, PCV2
replicates in porcine kidney epithelial cells [2, 20,
25, 32], and PCV2 isolation and production is
routinely performed using porcine kidney (PK-15)
and swine kidney (SK) epithelial cell lines [2, 32].
When PCV2 replication kinetics were studied in a
PK-15 epithelial cell line that was inoculated with
the prototype PCV2 strain Stoon-1010 [9], 1.8% of
cells were infected with a maximum yield of 3.9
log10 TCID50=ml in culture supernatant [22]. This
low yield slows down the production of PCV2
vaccines. Therefore, increasing the replication of
PCV2 in PK-15 cells will allow vaccine production
to be scaled up, making the production more effi-
cient and profitable.
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Earlier studies have shown that the number of
PCV2-infected cells can be enhanced by treatment
of PK-15 cells either with interferon-gamma (IFN-g)
[23] or inhibitors of endosomal-lysosomal system
acidification such as ammonium chloride (NH4Cl),
chloroquine diphosphate (CQ) and monensin [25].
In the study by Meerts et al. [23], the effect of IFN-
g treatment of PK-15 cells on the PCV2 yield was
also investigated, and it was shown that IFN-g
treatment increased the yield of progeny PCV2 by
20 times. Up till now, neither the effect of treatment
of PK-15 cells with the endosomal-lysosomal sys-
tem acidification inhibitors alone nor the effect of
treatment of PK-15 cells with the combination of
IFN-g and inhibitors of the endosomal-lysosomal
system acidification on PCV2 yield have been in-
vestigated. It was the aim of the present study to
investigate the combined effect of treating PK-15
cells with IFN-g and inhibitors of endosomal-lyso-
somal system acidification on PCV2 infection and
PCV2 yield.
To investigate the effect of IFN-g and inhibitors
of the endosomal-lysosomal system acidification
on the number of PCV2-infected cells, 2104
PK-15 cells that were free of porcine circoviruses
were seeded per well of a 96-well cell culture plate
(Nunc, Roskilde, Denmark). Cells were maintained
at 37 C in a humidified 5% CO2 incubator in cul-
ture medium containing 10% fetal bovine serum
(FBS; Invitrogen, Grand Island, U.S.A.), 0.3 mg=ml
L-glutamine (BDH Chemicals Ltd., Poole, England),
1% nonessential amino acids (100 ; Invitrogen),
1 mM sodium pyruvate (Invitrogen), 100 U=ml
penicillin, 0.1 mg=ml streptomycin and 0.1 mg=ml
kanamycin in RPMI-1640 (Invitrogen). Recombi-
nant porcine IFN-g (R & D systems, Abingdon,
U.K.) was dissolved and stored as previously de-
scribed [23]. Cell culture medium with or without
500 U=ml IFN-g was added to PK-15 cells at
6 h post-seeding. At 24 h post-seeding, cells were
washed and inoculated with prototype PCV2 strain
Stoon-1010 (5.3 log10 TCID50, 20
th passage) at a
Fig. 1. Effect of IFN-g and in-
hibitors of endosomal-lysosomal
system acidification on PCV2 in-
fection of PK-15 cells. Representa-
tive light microscopic images of
PK-15 cells treated with or without
IFN-g and=or CQ after performing
an IPMA staining to identify
PCV2-infected cells. Bar: 200mm
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multiplicity of infection (moi) of 0.3 at 37 C. After
1 h, the viral inoculum was washed off and cells
were incubated in cell culture medium with or
without 25 mM, 125 mM or 6mM of NH4Cl, CQ
or monensin, respectively. At 24 h post-inoculation
(hpi), cell culture medium with or without the en-
dosomal-lysosomal system inhibitors was replaced
with fresh cell culture medium without inhibitors
of endosomal-lysosomal system acidification. Cells
were fixed with methanol at 20 C for 10 min af-
ter the first cycle of PCV2 replication at 36 hpi [22].
PCV2-infected cells were identified by an immuno-
peroxidase monolayer assay (IPMA) using porcine
polyclonal anti-PCV2 antibodies [34] and horserad-
ish peroxidase-conjugated polyclonal rabbit anti-
swine immunoglobulins (DakoCytomation, Glostrup,
Denmark). Substrate was added to stain-infected
cells, which were then counted by examination
under a light microscope (Olympus Optical Co.,
Hamburg, Germany). The number of infected cells
per well in untreated PK-15 cells was used as a
reference, and all results were expressed as relative
percentages to this reference. All experiments were
performed three times with each condition in a sin-
gle experiment in quadruplicate.
Treatment of PK-15 cells either with IFN-g or
inhibitors of endosomal-lysosomal system acidifi-
cation increased the number of PCV2-infected cells
(Figs. 1 and 2), in agreement with previous studies
[23, 25]. Combined treatment of PK-15 cells with
IFN-g and inhibitors of endosomal-lysosomal sys-
tem acidification also increased the number of
PCV2-infected cells. The percentages of PCV2-
infected PK-15 cells at 36 hpi in untreated and treat-
ed PK-15 cells are shown in Table 1. From these
results, it can be concluded that inhibiting endo-
somal-lysosomal system acidification gives an ad-
ditional enhancement of PCV2 infection in PK-15
cells treated with IFN-g. This additional effect was
possible because IFN-g and inhibitors of endoso-
Fig. 2. The effect of IFN-g and inhibitors of endosomal-
lysosomal system acidification on the number of PCV2-
infected PK-15 cells. PK-15 cells were pre-treated with
(filled bars) or without (empty bars) IFN-g before they were
inoculated with PCV2. After PCV2 inoculation, cells were
incubated with or without inhibitors of endosomal-lysosom-
al system acidification for 24 h. Cells were fixed at 36 hpi
and PCV2-infected cells were counted following IPMA
staining. The number of PCV2-infected cells in untreated
cell cultures was taken as reference, and all values are re-
lative percentages of this reference
Table 1. Total PCV2 yield in untreated PK-15 cells and PK-15 cells treated with IFN-g, inhibitors of endosomal-lysosomal
system acidification, or a combination of IFN-g and inhibitors of endosomal-lysosomal system acidification
Lysosomotropic
agent
IFN-g (U=ml) % of PCV2-infected
cells at 36 hpi
PCV2 titre log10 (TCID50 per 10
5 cells)
1 hpi 24 hpi 48 hpi 72 hpi
Control 0 0.38 0.03 1.9 1.5 2.9 3.1
Control 500 1.71 0.12 2.0 2.1 3.4 3.9
NH4Cl 0 1.70 0.06 2.1 1.9 3.0 3.8
NH4Cl 500 6.67 1.57 1.6 3.0 4.0 4.8
CQ 0 3.97 0.31 1.4 1.8 3.3 4.3
CQ 500 8.47 1.23 1.6 2.3 4.0 4.6
Monensin 0 3.61 0.39 1.9 2.3 3.9 3.6
Monensin 500 7.52 1.17 2.0 2.8 4.6 4.8
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mal-lysosomal system acidification are known to
affect different stages of PCV2 infection. Previous
studies have shown that treatment of cells with
IFN-g increases PCV2 infection by increasing in-
ternalization of PCV2 particles into the cell [23],
while treatment of cells with inhibitors of the en-
dosomal-lysosomal system acidification increases
PCV2 infection by increasing disassembly of inter-
nalized PCV2 particles within the cell [25].
For virus yield assays, 2105 cells were seeded
per well of a 24-well cell culture plate (Nunc).
Cells were pre-treated with or without 500 U=ml
IFN-g at 6 h post-seeding. At 24 h post-seeding,
cells were washed and inoculated with the proto-
type PCV2 strain Stoon-1010 (5.3 log10 TCID50,
20th passage) at an moi of 0.3 for 1 h at 37 C.
The viral inoculum was washed off, and cells were
further incubated in culture medium with or with-
out 25 mM NH4Cl, 125 mM CQ or 6mM monensin
for 24 h. Then, the culture medium with or with-
out endosomal-lysosomal system acidification in-
hibitors was replaced with fresh culture medium
without inhibitors of endosomal-lysosomal system
acidification. All inhibitors of endosomal-lysosom-
al system acidification were removed at 24 hpi be-
cause one of the inhibitors, monensin, is a classical
exocytosis blocker [8, 10, 26, 36]. At 1, 24, 48 and
72 hpi, the cell culture supernatant was collected.
Cells were subjected to three freeze-thaw cycles.
Total virus yield (intra- and extracellular virus titres)
was determined on PCV2-negative PK-15 cells
by inoculation of a tenfold dilution series on PK-
15 cells in quadruplicate, as previously described
[24]. After 36 h of cultivation at 37 C in the pres-
ence of 5% CO2, cells were fixed in methanol at
20 C for 10 min. Viral antigens were detected
using an IPMA as described above, and PCV2 titres
were expressed as log10 TCID50 per 10
5 cells.
Treatment of PK-15 cells either with IFN-g or
inhibitors of endosomal-lysosomal system acidifi-
cation increased PCV2 yield (Table 1). Combined
treatment of PK-15 cells with IFN-g and inhibitors
of endosomal-lysosomal system acidification fur-
ther increased PCV2 yield. PCV2 yield increased
gradually under all conditions, with the highest yield
observed at 72 hpi. The highest recorded PCV2
yield was 4.8 log10 TCID50 per 10
5 treated cells
compared to 3.1 log10 TCID50 per 10
5 untreated
cells at 72 hpi. This is a 50-fold increase in PCV2
yield. The highest increase in PCV2 infection was
observed when PK-15 cells were treated with a
combination of IFN-g and CQ or NH4Cl.
The results of the present study show that a com-
bined inhibition of endosomal-lysosomal system
acidification and IFN-g treatment of PK-15 cells
increases the number of PCV2-infected cells and
PCV2 yield. Treatment of cells with a combination
of inhibitors of endosomal-lysosomal system acidi-
fication and IFN-g may be of use in increasing the
yield of PCV2 for PCV2 vaccine production.
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